Thomas McNerney & Partners LP
- SEC CIK
- 0001231291
No open-market purchases or sales filed in the past year.
Current role at each company
- CRXT Clarus Therapeutics Holdings, Inc.10% Owneras of Apr 25, 2022
- Clarus Therapeutics Inc10% Owneras of Apr 21, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Thomas McNerney & Partners LP as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CRXT Clarus Therapeutics Holdings, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 25, 2022 (view filing)5:17 PM ET | Apr 20 | 5 days | Thomas James E and 8 others10% Owner | SSale | −3.75M | $2.53 | −$9.49M | −99.9%3.53K after | Amended6 lots |
Clarus Therapeutics Inc
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2022 (view filing)7:04 PM ET | Apr 20 | 1 day | Thomas James E and 8 others10% Owner | SSale | −3.75M | $2.53 | −$9.49M | −99.9%3.53K after | 6 lots |